Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideJNJJohnson & Johnson
FinDog View：Bullish
ZBHZimmer Biomet
FinDog View：Neutral
| Metric | JNJ | ZBH |
|---|
| Close | 273.20 | 94.52 |
| Market Cap | $666B | $18.8B |
| 1M | +3.20% | +6.41% |
| P/E (TTM) | 41.3 | 22.3 |
| Forward P/E | 22.0 | 10.5 |
| P/E 5-Yr Percentile | 100 | 28 |
| P/S | 6.7 | 2.1 |
| P/B | 7.8 | 1.4 |
| Dividend Yield | 3.12% | 1.04% |
| Latest Quarter Revenue | $25.4B | $2.2B |
| Revenue YoY | +5.9% | +4.8% |
| Gross Margin | 68.1% | 70.8% |
| Latest Quarter EPS | 0.09 | 1.03 |
| Avg Post-Earnings Move | ±0.6% | ±2.1% |
| EPS Beat Rate | 1 / 1 | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.18% | 5.00% |
| 90-Day Net Insider Buying | −$62.0M | −$0.82M |
JNJ · Revenue, Last 8 Quarters ($B)
ZBH · Revenue, Last 8 Quarters ($B)
